Qi Peng

Title: The Innovative Contributions of Qi Peng in Pharmaceutical Formulation

Introduction

Qi Peng is a notable inventor based in Nanjing, Jiangsu Province, China. He has made significant contributions to the field of pharmaceutical formulation, particularly in the development of injectable medications. His work focuses on improving the stability and efficacy of drug formulations, which is crucial for patient treatment.

Latest Patents

One of Qi Peng's most recent patents is titled "Aripiprazole injectable suspension formulation having prolonged shelf life." This invention addresses the need for a stable injectable formulation of aripiprazole, a medication used to treat schizophrenia and related disorders. The patent outlines methods for prolonging the shelf life of this formulation, ensuring that it remains effective for longer periods.

Career Highlights

Qi Peng is currently associated with Nanjing Noratech Pharmaceuticals Co., Ltd., where he applies his expertise in pharmaceutical sciences. His innovative approach to drug formulation has positioned him as a valuable asset in the pharmaceutical industry. With a total of 1 patent to his name, he continues to push the boundaries of what is possible in medication development.

Collaborations

Qi Peng has worked alongside talented colleagues such as Yunzhe Sun and Cheng-Gang Lin. Their collaborative efforts contribute to the advancement of pharmaceutical technologies and the development of new treatment options.

Conclusion

In summary, Qi Peng's contributions to pharmaceutical formulation, particularly through his innovative patent on aripiprazole, highlight his commitment to improving patient care. His work exemplifies the importance of research and innovation in the medical field.